1. Home
  2. SWBI vs ENGN Comparison

SWBI vs ENGN Comparison

Compare SWBI & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smith & Wesson Brands Inc.

SWBI

Smith & Wesson Brands Inc.

HOLD

Current Price

$14.56

Market Cap

691.4M

Sector

Industrials

ML Signal

HOLD

Logo enGene Holdings Inc.

ENGN

enGene Holdings Inc.

HOLD

Current Price

$1.53

Market Cap

647.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SWBI
ENGN
Founded
1852
1999
Country
United States
Canada
Employees
N/A
82
Industry
Ordnance And Accessories
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
691.4M
647.1M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
SWBI
ENGN
Price
$14.56
$1.53
Analyst Decision
Strong Buy
Buy
Analyst Count
1
6
Target Price
$14.00
$21.08
AVG Volume (30 Days)
405.2K
2.1M
Earning Date
06-17-2026
06-11-2026
Dividend Yield
3.37%
N/A
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$474,661,000.00
N/A
Revenue This Year
$7.61
N/A
Revenue Next Year
$3.72
N/A
P/E Ratio
$291.20
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.73
$1.49
52 Week High
$15.79
$12.25

Technical Indicators

Market Signals
Indicator
SWBI
ENGN
Relative Strength Index (RSI) 44.96 22.55
Support Level $13.80 N/A
Resistance Level $15.24 $8.32
Average True Range (ATR) 0.41 0.57
MACD -0.12 -0.58
Stochastic Oscillator 18.00 0.07

Price Performance

Historical Comparison
SWBI
ENGN

About SWBI Smith & Wesson Brands Inc.

Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.

About ENGN enGene Holdings Inc.

enGene Holdings Inc is a clinical-stage biotechnology company mainstreaming genetic medicine through the delivery of therapeutics to mucosal tissues and other organs, with the goal of creating new ways to address diseases with high clinical needs, beginning with non-muscle invasive bladder cancer (NMIBC). The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Share on Social Networks: